Medicare Enrolled

Dr. Jason Fullmer, MD

Pediatric Hematology-Oncology · Austin, TX
Speaking/Promotional
11111 RESEARCH BLVD, Austin, TX 78759
5123809200
In practice since 2006 (19 years)
NPI: 1184796401 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Fullmer from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Fullmer? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Fullmer

Dr. Jason Fullmer is a pediatric hematology-oncology in Austin, TX, with 19 years in practice.

Between the years covered by Open Payments, Dr. Fullmer received a total of $101,073 from 29 pharmaceutical and/or device companies across 284 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pediatric hematology-oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Fullmer is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice$ $101,073 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$101,073
Total received (2018-2024)
Avg $14,439/year across 7 years
Top 3% in TX for pediatric hematology-oncology
29
Companies
284
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$95,351 (94.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$3,320 (3.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,402 (2.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$87
2023
$87
2022
$3,155
2021
$2,603
2020
$20,938
2019
$47,149
2018
$27,054

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Gilead Sciences, Inc.
$71,738
VERTEX PHARMACEUTICALS INCORPORATED
$26,617
AstraZeneca Pharmaceuticals LP
$590
Vertex Pharmaceuticals Incorporated
$477
GlaxoSmithKline, LLC.
$263
Chiesi USA, Inc.
$184
Insmed, Inc.
$153
Actelion Pharmaceuticals US, Inc.
$117
AbbVie, Inc.
$105
Regeneron Healthcare Solutions, Inc.
$87
PTC Therapeutics, Inc.
$73
Electromed, Inc.
$73
Philips North America LLC
$72
Biogen, Inc.
$63
Novartis Pharmaceuticals Corporation
$59
Teva Pharmaceuticals USA, Inc.
$58
Melinta Therapeutics, Inc.
$54
Baxter Healthcare
$54
Philips Electronics North America Corporation
$46
Resmed Corp
$35
Jazz Pharmaceuticals Inc.
$32
GENZYME CORPORATION
$22
Horizon Pharma plc
$16
Allergan Inc.
$15
ABBVIE INC.
$14
Fisher & Paykel Healthcare Inc
$14
Avadel Pharmaceuticals (USA), Inc.
$14
Genentech USA, Inc.
$14
Merck Sharp & Dohme Corporation
$13
Top 3 companies account for 97.9% of total payments
Associated products mentioned in payments ›
(8874) inCourage · (8876) Vest Therapy Und · (AK6) Vest Therapy · ACTIMMUNE · ASMANEX · Arikayce · Astral · BETHKIS · BREZTRI · BRONCHITOL · CREON · Cayston · Creon · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · EMFLAZA · Emflaza · FASENRA · Hillrom - Vest System Model 105 Home Care · Karbinal ER · NUCALA · ORKAMBI · Obstructive Sleep Apnea Device or Hospital Respiratory Equipment · PERTZYE · QVAR · SMARTVEST · SPINRAZA · SYMBICORT · SYMDEKO · TEZSPIRE · TRIKAFTA · XOLAIR · Xolair · Xyrem · ZENPEP · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (94%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pediatric hematology-oncology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for pediatric hematology-oncology in TX.

Looking for a pediatric hematology-oncology in Austin?
Compare pediatric hematology-oncologys in the Austin area by procedure volume, costs, and industry payment transparency.
Browse pediatric hematology-oncologys nearby

Geographic Context

Pediatric Hematology-Oncologys within 10 mi
6
Per 100K population
0.5
County median income
$97,169
Nearest hospital
ASCENSION SETON NORTHWEST
0.0 mi

Data Sources

Provider Registry✓ NPPESWeekly updates
Medicare Enrollment✓ PECOSMonthly updates
Practice Data— No dataN/A
Industry Payments✓ Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Fullmer is a pediatric hematology-oncology, and high industry engagement (speaking/promotional, top 3%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Fullmer receive payments from pharmaceutical companies?
Yes. Dr. Fullmer received a total of $101,073 from 29 companies across 284 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Fullmer) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Pediatric Hematology-Oncologys in Austin
Browse pediatric hematology-oncologys in Austin ranked by procedure volume and transparency data.
Highest volume
Top Pediatric Hematology-Oncologys in TX
Pediatric Hematology-Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pediatric Hematology-Oncologys in TX
Which TX pediatric hematology-oncologys receive the most from drug and device companies.
By company
Gilead Sciences, Inc. Payments to Doctors
See all physicians who received payments from Gilead Sciences, Inc..
By company
VERTEX PHARMACEUTICALS INCORPORATED Payments to Doctors
See all physicians who received payments from VERTEX PHARMACEUTICALS INCORPORATED.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →